A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

Optimal Clinical Trials, Auckland

Hawkes Bay Hospital, Hastings

Hospital Universitario Reina Sofia, Córdoba

Johns Hopkins Hospital, Baltimore

Ospedale Civile di Montichiari, Montichiari

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

Premier Neurology, Greenville

Neurology Associates PA, Maitland

University of South Florida, Tampa

Bakirkoy State Mental Hospital, Istanbul

Istanbul Universitesi - Cerrahpasa Cerrahpasa Tip Fakultesi, Istanbul

Katip Celebi University Ataturk Training and Research Hospital, Izmir

Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife

Neurology Clinic PC, Cordova

Hospital Universitario Virgen Macarena, Seville

Kocaeli University Hospital, Kocaeli

UC Health Neurology, Dayton

Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis, Owosso

Nemocnice Jihlava, Jihlava

Namik Kemal Universitesi Sagli Uygulama ve Arastirma Hastanesi, Süleymanpa?a

IRCCS Istituto Neurologico Neuromed, Pozzilli

Clinica Amo - Assistencia Medica Em Oncologia, Salvador

CEDOES - Diagnóstico e Pesquisa, Vitória

Fakultni nemocnice u sv. Anny, Brno

Charles University, Medical faculty, Hradec Kralove, Hradec Králové

Fakultni nemocnice Ostrava, Ostrava-Poruba

Pardubicka Krajska Nemocnice, Pardubice

Fakultni poliklinika VFN, Prague

Fakultni nemocnice Motol, Prague

Krajska zdravotni a.s Nemocnice Teplice o.z., Teplice

Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla, Rome

Azienda Ospedaliera Sant'Andrea, Rome

Neurocentrum Bydgoszcz sp. z o.o, Bydgoszcz

Care Clinic, Katowice

Centrum Neurologii Krzysztof Selmaj, Lodz

Przychodnia EuroMediCare, Wroc?aw

Hospital Universitari Vall d'Hebron, Barcelona